SERMORELIN 10MG
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It consists of the first 29 amino acids of human GHRH and is researched for its ability to stimulate the pituitary gland to produce and secrete growth hormone.
$95.00 Original price was: $95.00.$75.00Current price is: $75.00.
The information provided on this page is intended solely as a general summary. It does not encompass all potential research applications, handling procedures, safety precautions, interactions, or observed effects. These products are supplied strictly for laboratory and research purposes only. They are not intended for human consumption, medical use, veterinary use, or diagnostic purposes. This information must not be considered a substitute for professional expertise, judgment, or regulatory guidance.
Money Back Guarantee
Guaranteed Quality
Fast Shipping
10+ Years Experience
Frequently Bought Together
SEQUENCE/FORMULA
MOLECULAR WEIGHT
PUBCHEM CID
- Investigating its ability to naturally stimulate the release of growth hormone
- Analyzing its effects on improving body composition as part of aging studies
- Studying its potential to enhance deep sleep and recovery
- Researching its benefits for heart and circulatory system health
- Exploring its role in supporting stronger, healthier bones
- Sermorelin is a synthetic (man-made) version of the first 29 amino acids of Growth Hormone-Releasing Hormone (GHRH).
- It works by binding to and stimulating the GHRH receptor in the anterior pituitary gland, which is the body's "master gland."
- This stimulation prompts the pituitary to produce and secrete the body's own endogenous growth hormone (GH) in a natural, pulsatile rhythm.
- The released GH then circulates to the liver and other tissues, stimulating the production of insulin-like growth factor 1 (IGF-1).
- Unlike direct administration of synthetic GH, Sermorelin's action is regulated by the body's natural negative feedback mechanisms (like the hormone somatostatin), which helps maintain physiological levels and reduces the risk of side effects. It has a very short half-life of about 10-20 minutes.
- Walker, R. F. (2006). Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?. Clinical Interventions in Aging, 1(4), 307–308.
- Prakash, A., & Goa, K. L. (1999). Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs, 12(2), 139-157.
- Vittone, J., et al. (1997). Growth hormone-releasing hormone effects on body composition and functional status in normal-weight healthy older men. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 52(6), M360-M365.
- Khorram, O., et al. (2001). Effects of a 12-week-long, twice-daily treatment with growth hormone-releasing hormone (GHRH) in healthy elderly men. The Journal of Clinical Endocrinology & Metabolism, 86(6), 2699-2704.
